Molecular risk stratification to direct therapy in endometrial cancer: ready for the clinic?

被引：3
|
作者：
Creutzberg, C. L. [1 ]
Bosse, T. [2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Radiat Oncol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷 / 05期
关键词：
CELL-ADHESION MOLECULE; PROGNOSTIC-SIGNIFICANCE; CARCINOMA; CLASSIFICATION; RECURRENCE; EXPRESSION; L1CAM;
D O I：
10.1093/annonc/mdy098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1081 / 1082
页数：3
相关论文
共 50 条
  • [41] Hormone replacement therapy and risk of endometrial cancer
    Tavani, A
    La Vecchia, C
    Brinton, LA
    McTiernan, A
    TUMORI, 2001, 87 (05) : S20 - S21
  • [42] Molecular Genetic Factors of Risk Stratification of Lymph Node Metastasis in Endometrial Carcinoma
    Gilyadova, Aida
    Ishchenko, Anton
    Babayan, Julietta
    Avin, Max
    Sekacheva, Marina
    Reshetov, Igor
    CANCERS, 2024, 16 (21)
  • [43] ENDOMETRIAL CANCER IMMUNOHISTOCHEMICAL RISK STRATIFICATION IN A LARGE UTERINE-CONFINED CANCER SERIES
    Perrone, E.
    De Felice, F.
    Capasso, I.
    Arciuolo, D.
    Distefano, E.
    Lorusso, D.
    Zannoni, G. F.
    Scambia, G.
    Fanfani, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A72 - A72
  • [44] ENDOMETRIAL CANCER IMMUNOHISTOCHEMICAL RISK STRATIFICATION IN A LARGE UTERINE-CONFINED CANCER SERIES
    Perrone, E.
    De Felice, F.
    Capasso, I.
    Arciuolo, D.
    Distefano, E.
    Lorusso, D.
    Zannoni, G. F.
    Scambia, G.
    Fanfani, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A74 - A75
  • [45] Molecular target therapies in endometrial cancer: From the basic research to the clinic
    Gadducci, Angiolo
    Tana, Roberta
    Cosio, Stefania
    Fanucchi, Antonio
    Genazzani, Andrea Riccardo
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (05) : 239 - 249
  • [46] Combination of hormonal-based therapy in endometrial cancer: ready for prime time
    Santia, Maria Clara
    Vilches, Jose C.
    Ramirez, Pedro T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (11) : 1682 - 1683
  • [47] Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) for Improved Endometrial Cancer Management
    Gilks, Blake
    Talhouk, Aline
    McConechy, Melissa
    Huntsman, David G.
    Lee, Cheng-Han
    McAlpine, Jessica N.
    LABORATORY INVESTIGATION, 2016, 96 : 284A - 285A
  • [48] Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) for Improved Endometrial Cancer Management
    Gilks, Blake
    Talhouk, Aline
    McConechy, Melissa
    Huntsman, David G.
    Lee, Cheng-Han
    McAlpine, Jessica N.
    MODERN PATHOLOGY, 2016, 29 : 284A - 285A
  • [49] Molecular pathology as the basis of risk stratification of rectal cancer
    Blaeker, Hendrik
    ONKOLOGE, 2020, 26 (12): : 1112 - 1118
  • [50] Gene testing to tailor breast cancer therapy has arrived - Is it ready for the clinic?
    Sinha, Gunjan
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (15) : 1050 - 1051
12345